Antibiotic Prescribing Behavior Among French Intensivist: Construction and Validation of a Questionnaire
1 other identifier
observational
115
1 country
1
Brief Summary
Antibiotic resistance is a major threat in modern medicine. Overuse of antibiotics is an important driver of antibiotic resistance. However, some authors have shown that up to 50% of antibiotic treatments in critically ill patients are inappropriate, mostly because they are used in patients with non-bacterial infections. In order to improve antibiotic use, several antibiotic stewardship programs have been implemented worldwide. However, only few of them have taken into account the determinants of prescribing behaviors. Yet, these determinants have been shown to play a role among general practitioners of hospital doctors. Nevertheless, none of these factors have been studied among intensivists. The current project represent phase 1 of the study : construction and validation of a questionnaire.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 25, 2021
CompletedFirst Posted
Study publicly available on registry
March 29, 2021
CompletedStudy Start
First participant enrolled
August 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedAugust 19, 2021
August 1, 2021
1.1 years
March 25, 2021
August 18, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Content validity
Construction and validation of a questionnaire by 2 experts in reanimation and infectiology. This questionnaire will include these items: demographic datas, medical data concerning the use of antibiotics, social data exploring the collective and social components of antibiotic prescription, personal data in search of individual factors, attitude to antibiotic therapy.
months 18
Secondary Outcomes (1)
Face validity
months 18
Other Outcomes (1)
Construct validity
months 18
Interventions
For the validity of built, it is generally advisable to include a ratio of 100 participants for 30 questionnaire items. In order to have a suitable questionnaire, we will limit ourselves to 30 items which will be the size of our questionnaire. It was therefore planned to include 100 participants The selection of experts will be based on experience in this area, knowledge and availability. It will be a rescimant physician and an infectious disease doctor. Each expert will be invited in isolation to comment on the items in the questionnaire
Eligibility Criteria
Physicians with predominant intensive care practice and Resident, with a minimum of two-month experience in the intensive care unit can be participe at this study.
You may qualify if:
- Physicians with predominant intensive care practice
- Resident, with a minimum of two-month experience in the intensive care unit
You may not qualify if:
- Refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu St Etienne
Saint-Etienne, 42000, France
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Guillaume THIERY, MD PHD
CHU ST ETIENNE FRANCE
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2021
First Posted
March 29, 2021
Study Start
August 1, 2021
Primary Completion
September 1, 2022
Study Completion
September 1, 2022
Last Updated
August 19, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share